These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8835714)

  • 1. Comments on fluoxetine in carcinogenicity.
    Hoffman WP; Long GG
    J Clin Psychopharmacol; 1996 Aug; 16(4):335-9. PubMed ID: 8835714
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluoxetine hypophagia. Is there a role for serotonergic mechanisms in some circumstances?
    Clifton PG; Lee MD
    Trends Pharmacol Sci; 1997 Jun; 18(6):191-2. PubMed ID: 9226996
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential fluoxetine chloride (Prozac) toxicity in a newborn.
    Mhanna MJ; Bennet JB; Izatt SD
    Pediatrics; 1997 Jul; 100(1):158-9. PubMed ID: 9229710
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluoxetine use in early pregnancy.
    Källén B
    Birth Defects Res B Dev Reprod Toxicol; 2004 Dec; 71(6):395-6. PubMed ID: 15617019
    [No Abstract]   [Full Text] [Related]  

  • 5. Maternal exposure to fluoxetine during gestation and lactation affects the DNA methylation programming of rat's offspring: modulation by folic acid supplementation.
    Toffoli LV; Rodrigues GM; Oliveira JF; Silva AS; Moreira EG; Pelosi GG; Gomes MV
    Behav Brain Res; 2014 May; 265():142-7. PubMed ID: 24583191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term use of fluoxetine on fertility parameters in adult male rats.
    Bataineh HN; Daradka T
    Neuro Endocrinol Lett; 2007 Jun; 28(3):321-5. PubMed ID: 17627270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy.
    da-Silva VA; Altenburg SP; Malheiros LR; Thomaz TG; Lindsey CJ
    Braz J Med Biol Res; 1999 Jan; 32(1):93-8. PubMed ID: 10347775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro estrogenic activity of the antidepressant fluoxetine.
    Müller JC; Imazaki PH; Boareto AC; Lourenço EL; Golin M; Vechi MF; Lombardi NF; Minatovicz BC; Scippo ML; Martino-Andrade AJ; Dalsenter PR
    Reprod Toxicol; 2012 Aug; 34(1):80-5. PubMed ID: 22522098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemico-toxicological study of fluoxetine].
    Kazartsev IA; Voronkova LG
    Sud Med Ekspert; 2008; 51(4):31-5. PubMed ID: 18756763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratogenic effects of maternal antidepressant exposure on neural substrates of drug-seeking behavior in offspring.
    Forcelli PA; Heinrichs SC
    Addict Biol; 2008 Mar; 13(1):52-62. PubMed ID: 17850417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral evaluation of male and female mice pups exposed to fluoxetine during pregnancy and lactation.
    Lisboa SF; Oliveira PE; Costa LC; Venâncio EJ; Moreira EG
    Pharmacology; 2007; 80(1):49-56. PubMed ID: 17519559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species in the tumor niche triggers altered activation of macrophages and immunosuppression: Role of fluoxetine.
    Ghosh S; Mukherjee S; Choudhury S; Gupta P; Adhikary A; Baral R; Chattopadhyay S
    Cell Signal; 2015 Jul; 27(7):1398-412. PubMed ID: 25819340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments.
    Gottmann E; Kramer S; Pfahringer B; Helma C
    Environ Health Perspect; 2001 May; 109(5):509-14. PubMed ID: 11401763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weighted multiplicity adjustments for animal carcinogenicity tests.
    Westfall PH; Soper KA
    J Biopharm Stat; 1998 Mar; 8(1):23-44; discussion 45-53. PubMed ID: 9547426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk from low-dose exposures.
    Monro AM
    Science; 1994 Nov; 266(5188):1141. PubMed ID: 7973684
    [No Abstract]   [Full Text] [Related]  

  • 17. Waterborne and sediment toxicity of fluoxetine to select organisms.
    Brooks BW; Turner PK; Stanley JK; Weston JJ; Glidewell EA; Foran CM; Slattery M; La Point TW; Huggett DB
    Chemosphere; 2003 Jul; 52(1):135-42. PubMed ID: 12729696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal fluoxetine exposure alters motor performances of adolescent rats.
    Lee LJ; Lee LJ
    Dev Neurobiol; 2012 Aug; 72(8):1122-32. PubMed ID: 21714104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does fish oil or folic acid prevent vascular changes in female progeny caused by maternal exposure to fluoxetine?
    Higashi CM; Matsumoto AK; Gameiro JG; Moura KF; Higachi L; Oliveira LC; Barbosa DS; Moreira EG; Ceravolo GS
    Life Sci; 2016 May; 152():165-70. PubMed ID: 27021785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine effect on kidney water reabsorption.
    Moyses ZP; Nakandakari FK; Magaldi AJ
    Nephrol Dial Transplant; 2008 Apr; 23(4):1173-8. PubMed ID: 18065798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.